Cytokines and acute phase proteins in rheumatoid arthritis

Scandinavian Journal of Rheumatology

Volumn 23, Issue S100, 1994, Pages 9-19

  Duff, G W ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Acute phase proteins; C reactive protein; Cytokines; Growth factors; Interleukin; Receptor antagonist; Soluble binding protein; Tumour necrosis factor

Indexed keywords

ACUTE PHASE PROTEIN; C REACTIVE PROTEIN; COLONY STIMULATING FACTOR; CYTOKINE; GROWTH FACTOR; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; MARKER; SERUM AMYLOID A; TUMOR NECROSIS FACTOR; BIOLOGICAL MARKER; GROWTH PROMOTOR; INTERLEUKIN DERIVATIVE; INTERLEUKIN RECEPTOR;

ACUTE PHASE RESPONSE; CHRONIC INFLAMMATION; CONFERENCE PAPER; CONNECTIVE TISSUE DISEASE; DISEASE ACTIVITY; IMMUNOPATHOGENESIS; INFLAMMATION; INFLAMMATORY CELL; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; ARTICLE; CLASSIFICATION; HUMAN; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ACUTE-PHASE PROTEINS; AMYLOID PROTEIN SAA; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CYTOKINES; GROWTH SUBSTANCES; HUMAN; INTERLEUKINS; RECEPTORS, INTERLEUKIN; TUMOR NECROSIS FACTOR;

EID: 0028591801     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.3109/03009749409095197     Document Type: Article

References (76)

1. Cytokine abnormalities in inflammatory arthritis
2. Interleukin-1 and interleukin-1 antagonism
3. Interleukin-1 activity in the synovial fluid of patients with rheumatoid arthritis
4. Isolation of an interleukin-1 like factor from human joint effusions
5. Immune diseases: many roles for interleukin-1
6. Rheumatoid arthritis synovial dendritic cells produce interleukin-1
7. Release of interleukin-1 from human synovial tissue in vitro
8. Soluble IL-2 receptor in rheumatoid arthritis: correlation with disease activity IL-1 and IL-inhibition
9. Correlation of plasma interleukin-1 levels with disease activity in rheumatoid arthritis
10. Plasma levels of interleukin-1 alpha in rheumatoid arthritis
11. Mechanism of anaemia in rheumatoid arthritis: demonstration of raised interleukin-1 beta concentrations in anaemic patients and of interleukin-1 mediated suppression of normal erythropoieses and proliferation of human erythroleukaemia (HEL) cells in vitro
12. Interleukin-1 beta in synovial fluid in relating to local disease activity in rheumatoid arthritis
13. In situ hybridisation of interleukin-1 in CD14-positive cells in rheumatoid arthritis
14. Quantitative analysis of cytokine gene expression in rheumatoid arthritis
15. Interleukin-1 and tumor necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1 alpha
16. Serum interleukin-2 receptor in rheumatoid arthritis: a prognostic indicator of disease activity
17. A cartilage catabolic factor from synovium
18. Characterisation of catabolin, the major product of synovial tissue that induces resorption of cartilage proteoglycan in vitro
19. Interleukin-1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint
20. Human cartilage is degraded by rheumatoid arthritis synovial fluid but not recombinant cytokines in vitro
21. Augmented interleukin-1 production and HLA-DR expression in the synovium of rheumatoid arthritis patients: possible involvement in joint destruction
22. Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis
23. The presence of tumor necrosis factor activity in synovial exudate fluids from patients with osteoarthritis or rheumatoid arthritis
24. Immunoreactive tumor necrosis factor alpha and biological inhibitor(s) in synovial fluids from rheumatic patients
25. Tumour necrosis factor in synovial exudates
26. Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum
27. Transgenic mice expressing human tumor necrosis factor: a predictive genetic model of arthritis
28. Arthritogenic actions of recombinant IL-1 and tumor necrosis factor alpha in the rabbit: evidence for synergistic interactions between cytokines in vivo
29. Synergistic stimulation of fibroblast prostaglandin production by recombinant interleukin-1 and tumor necrosis factor
30. Increased TNF-alpha secretion by alveolar macrophages from patients with rheumatoid arthritis
31. Endotoxin-stimulated human monocyte secretion of interleukin-1, tumor necrosis factor alpha, and prostaglandin E2 shows stable interindividual differences
32. A human inhibitor of tumor necrosis factor
33. Urate crystals stimulate production of tumor necrosis factor alpha from human blood monocytes and synovial cells: cytokine mRNA and protein kinetics and cellular distribution
34. Treatment of rheumatoid arthritis with climeric monoclonal antibodies to TNF-α
35. Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides
36. Interferon β2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells
37. Regulation of synthesis and secretion of major rat acute phase proteins by recombinant human interleukin-6 (BSF-2/IL-6) in hepatocyte primary cultures
38. Excessive production of interleukin6/B cell stimulatory factor-2 in rheumatoid arthritis
39. In situ hybridisation of IL-6 in rheumatoid arthritis
40. Synovium as a source of interleukin-6 in vitro
41. IL3 and IL6 do not induce bone resorption in vitro
42. Interleukin-6 localisation in the synovial membrane in rheumatoid arthritis
43. Detection of interleukin-8 biological activity in synovial fluids from patients with rheumatoid arthritis and production of interleukin-8 mRNA by isolated synovial cells
44. Enhanced production of neutrophil-activation peptide-1/interleukin-8 in rheumatoid arthritis
45. Elevation of interleukin-8 (IL-8) levels in joint fluids of patients with rheumatoid arthritis and the induction by IL-8 of leukocyte infiltration and synovitis in rabbit joints
46. Interleukin 8 in rheumatoid and osteoarthritis
47. Cytokines in chronic inflammatory arthritis (I). Failure to detect T cell lymphokines (interleukin 2 and interleukin 3) and presence of macrophage colony stimulating factor (CSF-1) and a novel mast cell growth factor in rheumatoid arthritis
48. Cytokines in chronic inflammatory arthritis (II). Granulocyte-macrophage colony-stimulating factor in rheumatoid synovial effusions
49. Cytokines in chronic inflammatory arthritis (IV). Granulocyte/macrophage colony-stimulating factor-mediated induction of class II MHC antigen on human monocytes: a possible role in rheumatoid arthritis
50. Cytokines in chronic inflammatory arthritis (VI). Analysis of the synovial cells involved in granulocyte-macrophage colony-stimulating factor production and gene expression in rheumatoid arthritis and its regulation by IL-1 and tumor necrosis factor-alpha
51. Polypeptide growth factors: roles in normal and abnormal cell growth
52. Human epidermal growth factor for the stratification of synovial lining layer and neovascularization in rheumatoid arthritis
53. Polypeptide growth factors augment interleukin-1-induced release of prostaglandin E2 by rheumatoid arthritis synovial cells in vitro
54. Transforming growth factor beta: biological function and chemical structure
55. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis
56. Active and latent forms of transforming growth factor-beta activity in synovial effusions
57. Detection of transforming growth factor-beta in rheumatoid arthritis synovial tissue: lack of effect on spontaneous cytokine production in joint cell cultures
58. Transforming growth factor-beta production by synovial tissues from rheumatoid patients and streptococcal cell wall arthritic rats
59. Cytokines and growth regulation of synoviocytes from patients with rheumatoid arthritis and rats with streptococcal cell wall arthritis
60. Single base polymorphism at-511 in the human interleukin-1 beta gene
61. Single base polymorphism in the human tumor necrosis factor alpha (TNF-α) gene detectable by Ncol restriction of PCR product
62. Polymorphic tandem repeat region in human interleukin-1 alpha intron 6
63. Polymorphism in human IL-1 receptor antagonist gene intron-2 caused by variable members of an 86 bp tandem repeat
64. Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor
65. Interleukin-1 (IL-1) receptor blockade reduces endotoxin and Borrelia burgdorferi-stimulated IL-8 synthesis in human mononuclear cells
66. Co-ordinated antiinflammatory effects of interleukin 4: interleukin 4 suppresses interleukin-1 production but up-regulates gene expression and synthesis of interleukin-1 receptor antagonist
67. Soluble interleukin 2 receptors are released from human activated lymphoid cells in vitro
68. Characterisation of a tumor necrosis factor alpha inhibitor: evidence of immunological cross-reactivity with the TNF receptor
69. Two tumor necrosis factor binding proteins purified from human urine: evidence for immunological cross-reactivity with cell surface TNF receptors
70. Purification and characterisation of a novel soluble receptor for interleukin-1
71. The soluble type II interleukin-1 (IL-1) receptor binds and blocks processing of IL-1 precursor and loses affinity for IL-1β receptor antagonist
72. Molecular cloning of the interleukin-1 beta converting enzyme
73. Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1 beta converting enzyme
74. The validity of surrogate markers in rheumatic disease
75. The phenomenon of the acute phase response
76. Serum amyloid-A (SAA) protein concentration in inflammatory diseases and its relationship to the incidence of reactive systemic amyloidosis